{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:03:25Z","timestamp":1783562605594,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["JP23K06965"],"award-info":[{"award-number":["JP23K06965"]}]},{"name":"JSPS KAKENHI","award":["JP18K07501"],"award-info":[{"award-number":["JP18K07501"]}]},{"name":"JSPS KAKENHI","award":["JP19K07976"],"award-info":[{"award-number":["JP19K07976"]}]},{"name":"JSPS KAKENHI","award":["JP25K19032"],"award-info":[{"award-number":["JP25K19032"]}]},{"name":"JSPS KAKENHI","award":["JP24K02371"],"award-info":[{"award-number":["JP24K02371"]}]},{"name":"JSPS KAKENHI","award":["JP21K07465"],"award-info":[{"award-number":["JP21K07465"]}]},{"name":"JSPS KAKENHI","award":["JP20K20470"],"award-info":[{"award-number":["JP20K20470"]}]},{"name":"Sumitomo Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02116-7","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:16:39Z","timestamp":1758737799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Facilitated \u03b1-synuclein oligomer sharing among glial cells by a centrally acting connexin inhibitor attenuates a rapidly progressive multiple system atrophy-cerebellar type model by reducing the neuronal \u03b1-synuclein burden"],"prefix":"10.1186","volume":"13","author":[{"given":"Masaya","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Matsuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi Ozdemir","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuu-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Suzumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Taniwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"2116_CR1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107391119","volume":"119","author":"AA Almad","year":"2022","unstructured":"Almad AA, Taga A, Joseph J, Gross SK, Welsh C, Patankar A et al (2022) Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS. Proc Natl Acad Sci USA 119:e2107391119. https:\/\/doi.org\/10.1073\/pnas.2107391119","journal-title":"Proc Natl Acad Sci USA"},{"key":"2116_CR2","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1523\/JNEUROSCI.22-15-06458.2002","volume":"22","author":"BM Altevogt","year":"2002","unstructured":"Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL (2002) Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 22:6458\u20136470. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-15-06458.2002","journal-title":"J Neurosci"},{"key":"2116_CR3","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1523\/JNEUROSCI.3303-03.2004","volume":"24","author":"BM Altevogt","year":"2004","unstructured":"Altevogt BM, Paul DL (2004) Four classes of intercellular channels between glial cells in the CNS. J Neurosci 24:4313\u20134323. https:\/\/doi.org\/10.1523\/JNEUROSCI.3303-03.2004","journal-title":"J Neurosci"},{"key":"2116_CR4","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, Muggeo S, Massimino L, Marzi MJ, Giannelli SG, Melacini E et al (2021) Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun 12:6237. https:\/\/doi.org\/10.1038\/s41467-021-26519-x","journal-title":"Nat Commun"},{"key":"2116_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095023","volume":"9","author":"M Burkovetskaya","year":"2014","unstructured":"Burkovetskaya M, Karpuk N, Xiong J, Bosch M, Boska MD, Takeuchi H et al (2014) Evidence for aberrant astrocyte hemichannel activity in juvenile neuronal ceroid lipofuscinosis (JNCL). PLoS One 9:e95023. https:\/\/doi.org\/10.1371\/journal.pone.0095023","journal-title":"PLoS One"},{"key":"2116_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SIA, Deas E, Abramov AY, Chen AY, Orte A et al (2012) Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149:1048\u20131059. https:\/\/doi.org\/10.1016\/j.cell.2012.03.037","journal-title":"Cell"},{"key":"2116_CR7","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A et al (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220\u20139232. https:\/\/doi.org\/10.1523\/JNEUROSCI.2617-07.2007","journal-title":"J Neurosci"},{"key":"2116_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/biom13020269","volume":"13","author":"F De Nuccio","year":"2023","unstructured":"De Nuccio F, Kashyrina M, Serinelli F, Laferri\u00e8re F, Lofrumento DD, De Giorgi F et al (2023) Oligodendrocytes prune axons containing \u03b1-synuclein aggregates in vivo: Lewy neurites as precursors of glial cytoplasmic inclusions in multiple system atrophy? Biomolecules 13:269. https:\/\/doi.org\/10.3390\/biom13020269","journal-title":"Biomolecules"},{"key":"2116_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/glia.23631","volume":"67","author":"EF D\u00edaz","year":"2019","unstructured":"D\u00edaz EF, Labra VC, Alvear TF, Mellado LA, Inostroza CA, Oyarz\u00fan JE et al (2019) Connexin 43 hemichannels and pannexin-1 channels contribute to the \u03b1-synuclein-induced dysfunction and death of astrocytes. Glia 67:1598\u20131619. https:\/\/doi.org\/10.1002\/glia.23631","journal-title":"Glia"},{"key":"2116_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) \u03b1-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"2116_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/dvg.20808","volume":"50","author":"N Inamura","year":"2012","unstructured":"Inamura N, Sugio S, Macklin WB, Tomita K, Tanaka KF, Ikenaka K (2012) Gene induction in mature oligodendrocytes with a PLP-tTA mouse line. Genesis 50:424\u2013428. https:\/\/doi.org\/10.1002\/dvg.20808","journal-title":"Genesis"},{"key":"2116_CR12","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/mds.20537","volume":"20","author":"KA Jellinger","year":"2005","unstructured":"Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20:S29-36. https:\/\/doi.org\/10.1002\/mds.20537","journal-title":"Mov Disord"},{"key":"2116_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2005.08.027","volume":"136","author":"N Kamasawa","year":"2005","unstructured":"Kamasawa N, Sik A, Morita M, Yasumura T, Davidson KG, Nagy JI et al (2005) Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 136:65\u201386. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.08.027","journal-title":"Neuroscience"},{"key":"2116_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","volume":"131","author":"M Komatsu","year":"2007","unstructured":"Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T et al (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131:1149\u20131163. https:\/\/doi.org\/10.1016\/j.cell.2007.10.035","journal-title":"Cell"},{"key":"2116_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106551","volume":"198","author":"T Kon","year":"2024","unstructured":"Kon T, Forrest SL, Lee S, Li J, Chasiotis H, Nassir N et al (2024) SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurobiol Dis 198:106551. https:\/\/doi.org\/10.1016\/j.nbd.2024.106551","journal-title":"Neurobiol Dis"},{"key":"2116_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.expneurol.2009.10.005","volume":"221","author":"Y Lim","year":"2010","unstructured":"Lim Y, Kehm VM, Li C, Trojanowski JQ, Lee VMY (2010) Forebrain overexpression of \u03b1-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption. Exp Neurol 221:86\u201397. https:\/\/doi.org\/10.1016\/j.expneurol.2009.10.005","journal-title":"Exp Neurol"},{"key":"2116_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","volume":"82","author":"V Lindstr\u00f6m","year":"2017","unstructured":"Lindstr\u00f6m V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A et al (2017) Extensive uptake of \u03b1-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci 82:143\u2013156. https:\/\/doi.org\/10.1016\/j.mcn.2017.04.009","journal-title":"Mol Cell Neurosci"},{"key":"2116_CR18","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3791\/960","volume":"21","author":"L Liu","year":"2008","unstructured":"Liu L, Duff K (2008) A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J Vis Exp 21:960. https:\/\/doi.org\/10.3791\/960","journal-title":"J Vis Exp"},{"key":"2116_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41418-018-0150-3","volume":"26","author":"L Maatouk","year":"2019","unstructured":"Maatouk L, Yi C, Carrillo-de Sauvage MA, Compagnion AC, Hunot S, Ezan P et al (2019) Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity. Cell Death Differ 26:580\u2013596. https:\/\/doi.org\/10.1038\/s41418-018-0150-3","journal-title":"Cell Death Differ"},{"key":"2116_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroscience.2004.03.031","volume":"126","author":"W M\u00eame","year":"2004","unstructured":"M\u00eame W, Ezan P, Venance L, Glowinski J, Giaume C (2004) ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1 \u03b2 treatment in cultured astrocytes. Neuroscience 126:95\u2013104. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.03.031","journal-title":"Neuroscience"},{"key":"2116_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185989","volume":"12","author":"I Morales","year":"2017","unstructured":"Morales I, Sanchez A, Rodriguez-Sabate C, Rodriguez M (2017) Striatal astrocytes engulf dopaminergic debris in Parkinson\u2019s disease: a study in an animal model. PLoS One 12:e0185989. https:\/\/doi.org\/10.1371\/journal.pone.0185989","journal-title":"PLoS One"},{"key":"2116_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/glia.10278","volume":"44","author":"JI Nagy","year":"2003","unstructured":"Nagy JI, Ionescu AV, Lynn BD, Rash JE (2003) Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: implications from normal and connexin32 knockout mice. Glia 44:205\u2013218. https:\/\/doi.org\/10.1002\/glia.10278","journal-title":"Glia"},{"key":"2116_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00401-003-0811-1","volume":"107","author":"M Nishie","year":"2004","unstructured":"Nishie M, Mori F, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T et al (2004) Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol (Berl) 107:292\u2013298. https:\/\/doi.org\/10.1007\/s00401-003-0811-1","journal-title":"Acta Neuropathol (Berl)"},{"key":"2116_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bpa.13131","volume":"33","author":"Y Nishimura","year":"2023","unstructured":"Nishimura Y, Masaki K, Matsuse D, Yamaguchi H, Tanaka T, Matsuo E et al (2023) Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal\/paranodal pathology are characteristic of multiple system atrophy. Brain Pathol 33:1\u201316. https:\/\/doi.org\/10.1111\/bpa.13131","journal-title":"Brain Pathol"},{"key":"2116_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1471-4159.2011.07210.x","volume":"118","author":"JA Orellana","year":"2011","unstructured":"Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MVL, Naus CC et al (2011) ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 118:826\u2013840. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07210.x","journal-title":"J Neurochem"},{"key":"2116_CR26","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1523\/JNEUROSCI.6417-10.2011","volume":"31","author":"JA Orellana","year":"2011","unstructured":"Orellana JA, Shoji KF, Abudara V, Ezan P, Amigou E, S\u00e1ez PJ et al (2011) Amyloid \u03b2-induced death in neurons involves glial and neuronal hemichannels. J Neurosci 31:4962\u20134977. https:\/\/doi.org\/10.1523\/JNEUROSCI.6417-10.2011","journal-title":"J Neurosci"},{"key":"2116_CR27","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.1523\/JNEUROSCI.3395-07.2007","volume":"27","author":"JL Orthmann-Murphy","year":"2007","unstructured":"Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK (2007) Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J Neurosci 27:13949\u201313957. https:\/\/doi.org\/10.1523\/JNEUROSCI.3395-07.2007","journal-title":"J Neurosci"},{"key":"2116_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-006-0109-1","volume":"112","author":"T Ozawa","year":"2006","unstructured":"Ozawa T (2006) Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum. Acta Neuropathol 112:531\u2013538. https:\/\/doi.org\/10.1007\/s00401-006-0109-1","journal-title":"Acta Neuropathol"},{"key":"2116_CR29","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657\u20132671. https:\/\/doi.org\/10.1093\/brain\/awh303","journal-title":"Brain"},{"key":"2116_CR30","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","volume":"30","author":"KE Paleologou","year":"2010","unstructured":"Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim H-Y, Lamberto GR et al (2010) Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. J Neurosci 30:3184\u20133198. https:\/\/doi.org\/10.1523\/JNEUROSCI.5922-09.2010","journal-title":"J Neurosci"},{"key":"2116_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mcn.2015.02.015","volume":"65","author":"R Radford","year":"2015","unstructured":"Radford R, Rcom-H\u2019cheo-Gauthier A, Wong MB, Eaton ED, Quilty M, Blizzard C et al (2015) The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to \u03b1-synuclein inclusions. Mol Cell Neurosci 65:68\u201381. https:\/\/doi.org\/10.1016\/j.mcn.2015.02.015","journal-title":"Mol Cell Neurosci"},{"key":"2116_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110565","volume":"27","author":"A Raghavan","year":"2024","unstructured":"Raghavan A, Kashyap R, Sreedevi P, Jos S, Chatterjee S, Alex A et al (2024) Astroglia proliferate upon the biogenesis of tunneling nanotubes via \u03b1-synuclein dependent transient nuclear translocation of focal adhesion kinase. iScience 27:110565. https:\/\/doi.org\/10.1016\/j.isci.2024.110565","journal-title":"iScience"},{"key":"2116_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00401-019-02007-x","volume":"138","author":"JF Reyes","year":"2019","unstructured":"Reyes JF, Sackmann C, Hoffmann A, Svenningsson P, Winkler J, Ingelsson M et al (2019) Binding of \u03b1-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes. Acta Neuropathol 138:23\u201347. https:\/\/doi.org\/10.1007\/s00401-019-02007-x","journal-title":"Acta Neuropathol"},{"key":"2116_CR34","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1242\/jcs.200667","volume":"130","author":"TM Ribeiro-Rodrigues","year":"2017","unstructured":"Ribeiro-Rodrigues TM, Martins-Marques T, Morel S, Kwak BR, Gir\u00e3o H (2017) Role of connexin 43 in different forms of intercellular communication-gap junctions, extracellular vesicles and tunnelling nanotubes. J Cell Sci 130:3619\u20133630. https:\/\/doi.org\/10.1242\/jcs.200667","journal-title":"J Cell Sci"},{"key":"2116_CR35","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/brain\/awv040","volume":"138","author":"RF Roberts","year":"2015","unstructured":"Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2015) Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain. Brain 138:1642\u20131657. https:\/\/doi.org\/10.1093\/brain\/awv040","journal-title":"Brain"},{"key":"2116_CR36","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, Dansokho C, Mercan D, Schmidt SV, Bousset L, Wischhof L et al (2021) Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 184:5089-5106.e21. https:\/\/doi.org\/10.1016\/j.cell.2021.09.007","journal-title":"Cell"},{"key":"2116_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12031-012-9733-5","volume":"47","author":"L Schwarz","year":"2012","unstructured":"Schwarz L, Goldbaum O, Bergmann M, Probst-Cousin S, Richter-Landsberg C (2012) Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci 47:256\u2013266. https:\/\/doi.org\/10.1007\/s12031-012-9733-5","journal-title":"J Mol Neurosci"},{"key":"2116_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Hashimoto Y, Takata M, Nishida K, Futamura N et al (2025) Widespread distribution of \u03b1-synuclein oligomers in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol 149:42. https:\/\/doi.org\/10.1007\/s00401-025-02872-9","journal-title":"Acta Neuropathol"},{"key":"2116_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70374","volume":"21","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Ono D, DeTure M, Ross OA, Murray ME et al (2025) Impact of hippocampal \u03b1-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies. Alzheimers Dement 21:e70374. https:\/\/doi.org\/10.1002\/alz.70374","journal-title":"Alzheimers Dement"},{"key":"2116_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","volume":"137","author":"H Sekiya","year":"2019","unstructured":"Sekiya H, Kowa H, Koga H, Takata M, Satake W, Futamura N et al (2019) Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol 137:455\u2013466. https:\/\/doi.org\/10.1007\/s00401-019-01961-w","journal-title":"Acta Neuropathol"},{"key":"2116_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-022-01440-6","volume":"10","author":"H Sekiya","year":"2022","unstructured":"Sekiya H, Tsuji A, Hashimoto Y, Takata M, Koga S, Nishida K et al (2022) Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson\u2019s disease. Acta Neuropathol Commun 10:1\u201313. https:\/\/doi.org\/10.1186\/s40478-022-01440-6","journal-title":"Acta Neuropathol Commun"},{"key":"2116_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymeth.2014.08.016","volume":"70","author":"EC Stack","year":"2014","unstructured":"Stack EC, Wang C, Roman KA, Hoyt CC (2014) Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of tyramide signal amplification, multispectral imaging and multiplex analysis. Methods 70:46\u201358. https:\/\/doi.org\/10.1016\/j.ymeth.2014.08.016","journal-title":"Methods"},{"key":"2116_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41583-023-00697-7","volume":"24","author":"N Stefanova","year":"2023","unstructured":"Stefanova N, Wenning GK (2023) Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms. Nat Rev Neurosci 24:334\u2013346. https:\/\/doi.org\/10.1038\/s41583-023-00697-7","journal-title":"Nat Rev Neurosci"},{"key":"2116_CR44","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00702-04-1209-z","volume":"121","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Ono K, Sawada M (2014) Protective effect of INI-0602, a gap junction inhibitor, on dopaminergic neurodegeneration of mice with unilateral 6-hydroxydopamine injection. J Neural Transm (Vienna) 121:1349\u20131355. https:\/\/doi.org\/10.1007\/s00702-04-1209-z","journal-title":"J Neural Transm (Vienna)"},{"key":"2116_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-61508-2","volume":"14","author":"EO Takase","year":"2024","unstructured":"Takase EO, Yamasaki R, Nagata S, Watanabe M, Masaki K, Yamaguchi H et al (2024) Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model. Sci Rep 14:1\u201323. https:\/\/doi.org\/10.1038\/s41598-024-61508-2","journal-title":"Sci Rep"},{"key":"2116_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021108","volume":"6","author":"H Takeuchi","year":"2011","unstructured":"Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J et al (2011) Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer\u2019s disease. PLoS One 6:e21108. https:\/\/doi.org\/10.1371\/journal.pone.0021108","journal-title":"PLoS One"},{"key":"2116_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/brain\/awp282","volume":"133","author":"J Tong","year":"2010","unstructured":"Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M et al (2010) Brain \u03b1-synuclein accumulation in multiple system atrophy, Parkinson\u2019s disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172\u2013188. https:\/\/doi.org\/10.1093\/brain\/awp282","journal-title":"Brain"},{"key":"2116_CR48","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1021\/acsbiomaterials.1c01459","volume":"8","author":"AN Trementozzi","year":"2022","unstructured":"Trementozzi AN, Zhao C, Smyth H, Cui Z, Stachowiak JC (2022) Gap junction-mediated delivery of polymeric macromolecules. ACS Biomater Sci Eng 8:1566\u20131572. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c01459","journal-title":"ACS Biomater Sci Eng"},{"key":"2116_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M et al (2017) Microrna-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329. https:\/\/doi.org\/10.3389\/fnmol.2017.00329","journal-title":"Front Mol Neurosci"},{"key":"2116_CR50","doi-asserted-by":"publisher","first-page":"17194","DOI":"10.1073\/pnas.1006785107","volume":"107","author":"X Wang","year":"2010","unstructured":"Wang X, Veruki ML, Bukoreshtliev NV, Hartveit E, Gerdes HH (2010) Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels. Proc Natl Acad Sci USA 107:17194\u201317199. https:\/\/doi.org\/10.1073\/pnas.1006785107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2116_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-11-38","volume":"11","author":"J Xu","year":"2014","unstructured":"Xu J, Zhu MD, Zhang X, Tian H, Zhang JH, Wu XB et al (2014) Nf\u03bab-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice. J Neuroinflammation 11:38. https:\/\/doi.org\/10.1186\/1742-2094-11-38","journal-title":"J Neuroinflammation"},{"key":"2116_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbi.2024.07.004","volume":"121","author":"H Yamaguchi","year":"2024","unstructured":"Yamaguchi H, Nishimura Y, Matsuse D, Sekiya H, Masaki K, Tanaka T et al (2024) A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of \u03b1-synuclein oligomers and phosphorylated \u03b1-synuclein aggregates. Brain Behav Immun 121:122\u2013141. https:\/\/doi.org\/10.1016\/j.bbi.2024.07.004","journal-title":"Brain Behav Immun"},{"key":"2116_CR53","doi-asserted-by":"publisher","first-page":"20875","DOI":"10.18632\/oncotarget.5205","volume":"6","author":"HM Yun","year":"2015","unstructured":"Yun HM, Park KR, Kim EC, Hong JT (2015) PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption. Oncotarget 6:20875\u201320884. https:\/\/doi.org\/10.18632\/oncotarget.5205","journal-title":"Oncotarget"},{"key":"2116_CR54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/WNR.0000000000001209","volume":"30","author":"XM Zhang","year":"2019","unstructured":"Zhang XM, Wang LZ, He B, Xiang YK, Fan LX, Wang Q et al (2019) The gap junction inhibitor INI-0602 attenuates mechanical allodynia and depression-like behaviors induced by spared nerve injury in rats. NeuroReport 30:369\u2013377. https:\/\/doi.org\/10.1097\/WNR.0000000000001209","journal-title":"NeuroReport"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02116-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:16:40Z","timestamp":1758737800000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02116-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2116"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02116-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimental procedures were designed to minimise both the number of animals used and animal suffering. All animal experiments were conducted according to the guidelines for the proper conduct of animal experiments published by the Science Council of Japan. Ethical approval for the study was granted by the Animal Care and Use Committee of Kyushu University (approval number A22-283). The Animal Research Reporting of In Vivo Experiments (ARRIVE) guidelines for animal research were followed. All brain autopsies were performed with the consent of the legal next-of-kin or an individual with legal authority to grant permission for autopsy. The histological study of human tissue was approved by the Kyushu University Institutional Review Board for Clinical Research (22006-00).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.M. reports a grant from JSPS KAKENHI (Grant No. JP23K06965) and speaker honoraria from Novartis Pharma, Biogen Japan, Alexion Pharma, Chugai Pharmaceutical, Argenx Japan, and Mitsubishi Tanabe Pharma Corporation. T.T. is employed by Sumitomo Pharma Co., Ltd. H.S. reports fellowships from the Japanese Society of Neurology, the Cell Science Research Foundation, and the Uehara Memorial Foundation. He is partially supported by the American Parkinson Disease Association Research Grant, the Multiple System Atrophy Coalition Research Grant, the State of Florida Ed and Ethel Moore Alzheimer\u2019s Disease Research Program (24A08), and the Jaye F. and Betty F. Dyer Foundation Fellowship in progressive supranuclear palsy research. D.M. reports grants from JSPS KAKENHI (Grant No. JP24K10662) and the Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan (23FC2001); and speaking fees and\/or honoraria from Daiichi Sankyo Co. Ltd., Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Novartis Pharma, Takeda Pharmaceutical Co. Ltd., FP Co. Ltd., and Eisai Co. Ltd. E.T. has received honoraria from Novartis, Takeda Pharmaceutical, UCB Japan, Biogen Japan, and Mitsubishi Tanabe Pharmaceutical. Y.K. has received honoraria for lectures from UCB Japan, Novartis Pharma, Chugai Pharmaceutical. R.Y. has received honoraria from Argenx, Ono Pharmaceutical, Takeda Pharmaceutical, Eisai, Novartis, PDR Pharma, UCB Japan, and Kyowa Kirin. N.I. reports grants from JSPS KAKENHI (Grant No. JP24K02371), AMED Japan (Grant No. 24wm0625504s01001), the Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan (23FC1009), Sumitomo Pharma, Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma, Novartis Pharma, Biogen Japan, Yamasa Corporation, Kyowa Kirin Co., Ltd., and Nippon Boehringer Ingelheim Co., Ltd.; and honoraria from Alexion Pharma, Novartis Pharma, Argenx, Mitsubishi Tanabe Pharma, Biogen Japan, Takeda Pharmaceutical Co. Ltd., UCB Japan, Ono Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Teijin Healthcare Co. Ltd., Amgen Inc., and Eisai Co. Ltd. H.T. reports grants from JSPS KAKENHI (Grant No. JP21K07465 and JP24K10626), the Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan (Grant No. 23FC1009), and the Naito Foundation; and consultancy fees, speaking fees, and\/or honoraria from Alexion Pharma G.K., Biogen Japan Ltd., Chugai Pharmaceutical Co. Ltd., Cosmic Corporation Co. Ltd., Eisai Co. Ltd., Kowa Co. Ltd., Kyowa Kirin Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB Japan Co. Ltd. J.K. reports research funds from Sumitomo Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, and Yamasa Corporation; and consultancy fees, speaking fees, and\/or honoraria from Novartis Pharma, Argenx, Biogen Japan, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Alexion Pharma, and Kyushu University. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}